Prot #GR41675: A Phase III, Multicenter, Randomized Study of Efficacy, Safety, and Pharmacokinetics of the Port Delivery System with Ranibizumab in Patients with Diabetic Retinopathy (PAVILION)

Project: Research project

Project Details

StatusActive
Effective start/end date8/21/20 → 2/28/25

Funding

  • Genentech, Inc ((OE) Prot #GR41675)